Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue
Zhi Li, Zewen Kelvin Tuong, Isaac Dean, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Clinical implications of T cell exhaustion for cancer immunotherapy
Andrew Chow, Karlo Perica, Christopher A. Klebanoff, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 12, pp. 775-790
Open Access | Times Cited: 488
Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes
Maha K. Rahim, Trine Line Hauge Okholm, Kyle B. Jones, et al.
Cell (2023) Vol. 186, Iss. 6, pp. 1127-1143.e18
Open Access | Times Cited: 209
Cancer vaccines: Building a bridge over troubled waters
MacLean C. Sellars, Catherine J. Wu, Edward F. Fritsch
Cell (2022) Vol. 185, Iss. 15, pp. 2770-2788
Open Access | Times Cited: 188
Targeted modulation of immune cells and tissues using engineered biomaterials
Parisa Yousefpour, Kaiyuan Ni, Darrell J. Irvine
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 2, pp. 107-124
Open Access | Times Cited: 82
T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control
Maria M. Steele, Abhinav Jaiswal, Ines Delclaux, et al.
Nature Immunology (2023) Vol. 24, Iss. 4, pp. 664-675
Open Access | Times Cited: 79
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
Joy A. Pai, Matthew D. Hellmann, Jennifer L. Sauter, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 776-790.e7
Open Access | Times Cited: 67
Stem-like exhausted and memory CD8+ T cells in cancer
Thomas Gebhardt, Simone L. Park, Ian A. Parish
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 780-798
Closed Access | Times Cited: 63
Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity
Isaac Dean, Colin Y. C. Lee, Zewen Kelvin Tuong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 46
Isolation of tumour-reactive lymphocytes from peripheral blood via microfluidic immunomagnetic cell sorting
Zongjie Wang, Sharif Uddin Ahmed, Mahmoud Labib, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 9, pp. 1188-1203
Closed Access | Times Cited: 27
Chronic antigen in solid tumors drives a distinct program of T cell residence
Noah Veis Gavil, Milcah C. Scott, Eyob Weyu, et al.
Science Immunology (2023) Vol. 8, Iss. 84
Open Access | Times Cited: 27
Cellular and molecular waypoints along the path of T cell exhaustion
Xin Lan, Caitlin C. Zebley, Ben Youngblood
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 25
Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment
Qianting Guan, Meiwen Han, Qinghao Guo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Colin Y. C. Lee, Bethany C. Kennedy, Nathan Richoz, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Lymphatic vessels in the age of cancer immunotherapy
Triantafyllia Karakousi, Tenny Mudianto, Amanda W. Lund
Nature reviews. Cancer (2024) Vol. 24, Iss. 6, pp. 363-381
Closed Access | Times Cited: 14
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle
Wen‐Ping Lin, Hao Li, Zhi‐Jun Sun
EBioMedicine (2024) Vol. 104, pp. 105154-105154
Open Access | Times Cited: 9
Resident memory T cells and cancer
Noah Veis Gavil, Katarina Cheng, David Masopust
Immunity (2024) Vol. 57, Iss. 8, pp. 1734-1751
Closed Access | Times Cited: 9
Anti-PD-1 therapy triggers Tfh cell–dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes
Mathilde Ruggiu, Marion V. Guérin, Béatrice Corre, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 4
Open Access | Times Cited: 8
Intratumoral antigen signaling traps CD8 + T cells to confine exhaustion to the tumor site
Munetomo Takahashi, Tsz Y. So, Vitalina Chamberlain-Evans, et al.
Science Immunology (2024) Vol. 9, Iss. 95
Open Access | Times Cited: 8
The tumor-draining lymph node as a reservoir for systemic immune surveillance
Ines Delclaux, Katherine S. Ventre, Dennis Jones, et al.
Trends in cancer (2023) Vol. 10, Iss. 1, pp. 28-37
Open Access | Times Cited: 20
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies
Brianna M. Lax, Joseph R. Palmeri, Emi A. Lutz, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 31
Open Access | Times Cited: 19
Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly
Isabella A. T. M. Ferreira, Colin Y. C. Lee, William S. Foster, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 112991-112991
Open Access | Times Cited: 16
Fluorescence tracking demonstrates T cell recirculation is transiently impaired by radiation therapy to the tumor
Gwen Kramer, Tiffany C. Blair, Shelly Bambina, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Stem cell like memory T cells: A new paradigm in cancer immunotherapy
Fengdi Wang, Fanjun Cheng, Zheng Fang
Clinical Immunology (2022) Vol. 241, pp. 109078-109078
Open Access | Times Cited: 26
Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma
Alexandre V. Hirayama, Erik L. Kimble, Jocelyn H. Wright, et al.
Blood Advances (2023) Vol. 8, Iss. 2, pp. 453-467
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top